top of page
65829765_2319124654822835_2075102277852463104_n.jpg

Advanced Medical Imaging with AI

aetherAI focuses its technology development on digital pathology, striving to realize the ultimate value of digital medical imaging. By elevating the standards of medical image analysis and improving the quality of care, we aim to establish competitive barriers in niche markets and achieve world-class excellence.

Digital Imaging System Designed for Modern Pathology

Through seamless image management and an intuitive user interface, aetherAI's products help healthcare and academic institutions systematically manage pathology images, meeting the diverse needs of routine slide review and digital education.

Digital Pathology System

FDA-cleared (K233126)*, TFDA-approved (License No. 006777)*, and CE-marked.*

Digital Pathology Educational Platform (Cloud-Based)

群組 1.png
101690.png
群組 1.png
圖片 8.png

AI Pathology Image Analysis Applications

aetherAI collaborates with research institutions to develop a series of AI pathology image analysis applications. The technologies cover slide quality control, slide image management, target region feature recognition, cell counting, and IHC staining quantification, to provide reference support for pathology image research and data analysis.

AI Medical Imaging Software Solution

aetherAI provides software-only AI solutions that can be deeply integrated with existing imaging equipment in healthcare institutions, integrating artificial intelligence into clinical workflows.

Bone Marrow Smear Analysis Software

TFDA-approved (License No. 007251)* and CE-marked*.

Computer-aided Polyp Detection (CADe) Systems for Colonoscopy

TFDA-approved (License No. 007508)*.

群組 1.png
*For further information on TFDA-approved, FDA-cleared, or CE-marked products,
or to request detailed product information and business inquiries, please contact us
at sales.overseas@aetherai.com.
bottom of page